3,116
Views
5
CrossRef citations to date
0
Altmetric
Note

Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines

, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 587-591 | Received 07 Oct 2021, Accepted 18 Mar 2022, Published online: 05 May 2022

References

  • Almufarrij, I., and K. J. Munro. 2021. “One Year on: An Updated Systematic Review of SARS-CoV-2, COVID-19 and Audio-Vestibular Symptoms.” International Journal of Audiology 60 (12): 935–945.
  • Avcı, H., B. Karabulut, H. D. Eken, A. Faraşoğlu, T. Çakil, S. Çoruk, H. Özel, et al. 2021. “Otolaryngology-Specific Symptoms May Be Highly Observed in Patients with a History of Covid-19 Infection after Inactivated Coronavirus Vaccination.” Ear, Nose & Throat Journal 1455613211028493. doi:10.1177/01455613211028493.
  • Baden, L. R., H. M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, et al. 2021. “Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.” New England Journal of Medicine 384 (5): 403–416. doi:10.1056/NEJMoa2035389.
  • Baxter, R., N. Lewis, P. Bohrer, T. Harrington, L. Aukes, and N. P. Klein. 2016. “Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered Analysis.” Otolaryngology-Head and Neck Surgery 155 (1): 81–86. doi:10.1177/0194599816639043.
  • Briggs, S. E., M. J. Brenner, and S. S. Chandrasekhar. 2021. “Sudden Sensorineural Hearing Loss and COVID-19 Vaccination.” JAMA Otolaryngology – Head & Neck Surgery 148 (2): 196–197.
  • Carol Liu, Y. C., T. Ibekwe, J. M. Kelso, N. P. Klein, N. Shehu, W. Steuerwald, S. Aneja, et al. 2020. “Sensorineural Hearing Loss (SNHL) as an Adverse Event following Immunization (AEFI): Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data.” Vaccine 38 (30): 4717–4731. doi:10.1016/j.vaccine.2020.05.019.
  • Chang, C. W. D., E. D. McCoul, S. E. Briggs, E. A. Guardiani, M. L. Durand, et al. 2021. “Corticosteroid Use in Otolaryngology: Current Considerations during the COVID-19 Era.” Otolaryngology – Head & Neck Surgery. 1945998211064275. doi:10.1177/01945998211064275
  • Cirillo, N., and R. Doan. 2021. “The Association between COVID-19 Vaccination and Bell’s Palsy.” Lancet Infectious Diseases 22 (1): 5–6.
  • Comirnaty. 2021. “Summary of product characteristics, European agency of medicines.” Accessed 25 August 2021. https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdf.
  • El Sahly, H. M., L. R. Baden, B. Essink, S. Doblecki-Lewis, J. M. Martin, E. J. Anderson, T. B. Campbell, et al. 2021. “Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.” New England Journal of Medicine 385 (19): 1774–1785. doi:10.1056/NEJMoa2113017.
  • Formeister, E. J., W. Chien, Y. Agrawal, J. P. Carey, C. M. Stewart, and D. Q. Sun. 2021. “Preliminary Analysis of Association between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System Data.” JAMA Otolaryngology- Head & Neck Surgery 147 (7): 674. doi:10.1001/jamaoto.2021.0869.
  • Frazier, K. M., J. E. Hooper, H. H. Mostafa, and C. M. Stewart. 2020. “SARS-CoV-2 Virus Isolated from the Mastoid and Middle Ear: Implications for COVID-19 Precautions during Ear Surgery.” JAMA Otolaryngology- Head & Neck Surgery 146 (10): 964–966. doi:10.1001/jamaoto.2020.1922.
  • Greco, A., G. F. Macri, A. Gallo, M. Fusconi, A. De Virgilio, G. Pagliuca, C. Marinelli, et al. 2014. “Is Vestibular Neuritis an Immune Related Vestibular Neuropathy Inducing Vertigo?” Journal of Immunology Research 2014: 459048. doi:10.1155/2014/459048.
  • Huang, H. H., C. C. Huang, P. Y. Hsueh, and T. J. Lee. 2010. “Bilateral Sudden Deafness following H1N1 Vaccination.” Otolaryngology-Head and Neck Surgery 143 (6): 849–850. doi:10.1016/j.otohns.2010.05.018.
  • Jeong, J., and H. S. Choi. 2021. “Sudden Sensorineural Hearing Loss after COVID-19 Vaccination.” International Journal of Infectious 113: 341–343. doi:10.1016/j.ijid.2021.10.025.
  • Jeong, M., K. E. Ocwieja, D. Han, P. A. Wackym, Y. Zhang, A. Brown, C. Moncada, et al. 2021. “Direct SARS-CoV-2 Infection of the Human Inner Ear May Underlie COVID-19-Associated Audiovestibular Dysfunction.” Communications Medicine 1 (1): 44. doi:10.1038/s43856-021-00044-w.
  • Layton, D., C. Key, and S. A. Shakir. 2003. “Prolongation of the QT Interval and Cardiac Arrhythmias Associated with Cisapride: Limitations of the Pharmacoepidemiological Studies Conducted and Proposals for the Future.” Pharmacoepidemiology and Drug Safety 12 (1): 31–40. doi:10.1002/pds.781.
  • Lopez Bernal, J., N. Andrews, C. Gower, E. Gallagher, R. Simmons, S. Thelwall, J. Stowe, et al. 2021. “Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.” The New England Journal of Medicine 385 (7): 585–594. doi:10.1056/NEJMoa2108891.
  • Mutsch, M., W. Zhou, P. Rhodes, M. Bopp, R. T. Chen, T. Linder, C. Spyr, et al. 2004. “Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell’s Palsy in Switzerland.” New England Journal of Medicine 350 (9): 896–903. doi:10.1056/NEJMoa030595.
  • Naranjo, C. A., U. Busto, E. M. Sellers, P. Sandor, I. Ruiz, E. A. Roberts, E. Janecek, et al. 1981. “A Method for Estimating the Probability of Adverse Drug Reactions.” Clinical Pharmacology and Therapeutics 30 (2): 239–245. doi:10.1038/clpt.1981.154.
  • Our World in Data. 2021. “Coronavirus (COVID-19) vaccinations – statistics.” Accessed 28 August 2021. https://ourworldindata.org/covid-vaccinations?country=OWID_WRL
  • Ozonoff, A., E. Nanishi, and O. Levy. 2021. “Bell’s Palsy and SARS-CoV-2 Vaccines.” Lancet Infectious Diseases 21 (4): 450–452. doi:10.1016/S1473-3099(21)00076-1.
  • Parrino, D., A. Frosolini, C. Gallo, R. D. De Siati, G. Spinato, and C. de Filippis. 2021. “Tinnitus following COVID-19 Vaccination: Report of Three Cases.” International Journal of Audiology 1–4. doi:10.1080/14992027.2021.1931969.
  • Polack, F. P., S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J. L. Perez, C4591001 Clinical Trial Group, et al. 2020. “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.” The New England Journal of Medicine 383 (27): 2603–2615. doi:10.1056/NEJMoa2034577.
  • Rausch, C. 2021. COVID-19 Vaccine - Hearing Loss. Uppsala, Sweden: Uppsala Monitoring Centre.
  • Schwarzinger, M., V. Watson, P. Arwidson, F. Alla, and S. Luchini. 2021. “COVID-19 Vaccine Hesitancy in a Representative Working-Age Population in France: A Survey Experiment Based on Vaccine Characteristics.” The Lancet Public Health 6 (4): e210–e221. doi:10.1016/S2468-2667(21)00012-8.
  • Spikevax. 2021. “Summary of Product Characteristics, European Agency of Medicines.” Accessed on 25 August 2021. https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdf
  • Tsetsos, N., A. Poutoglidis, K. Vlachtsis, A. Kilmpasanis, and S. Gougousis. 2021. “Sudden Sensorineural Hearing Loss following the Second Dose of COVID-19 Vaccine.” Cureus 13 (8): e17435. doi:10.7759/cureus.17435.
  • Uppsala Monitoring Center 2021. VigiLyze, WHO Program for Pharmacovigilance. Uppsala, Sweden: Uppsala Monitoring Center.
  • Wichova, H., M. E. Miller, and M. J. Derebery. 2021. “Otologic Manifestations after COVID-19 Vaccination: The House Ear Clinic Experience.” Otology & Neurotology 42 (9): e1213–e1218. doi:10.1097/MAO.0000000000003275.
  • Yigit, M., A. Ozkaya-Parlakay, and E. Senel. 2021. “Evaluation of COVID-19 Vaccine Refusal in Parents.” The Pediatric Infectious Disease Journal 40 (4): e134–e136. doi:10.1097/INF.0000000000003042.